Drugs / ASK8007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00411424 | Sep 2007 → Jun 2009 | rheumatoid arthritis | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASK8007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00411424 ↗ |
| Action | Inhibit | “Osteopontin inhibitor” CHEMBL2109530 ↗ |
| Target | SPP1 | “Osteopontin inhibitor” CHEMBL2109530 ↗ |